Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: Assessment of efficacy and safety

摘要

Introduction: Clinical data are scarce for furosemide administered as a low-dose (<160 mg/24 hours) continuous intravenous infusion in acute heart failure (HF). Our purpose was to evaluate the efficacy and safety of low-dose continuous infusion of furosemide on diuretic response, renal function, and patient outcomes. Methods: A retrospective study of patients with acute HF who received furosemide administered as a continuous infusion after initial therapy with intermittent boluses (usually 40-80 mg every 12 hours). End points included mean hourly urine output, incidence of acute renal injury, and outcome disparities of patients who developed acute renal injury. Comparison of patients with preserved and reduced left ventricular ejection fraction (LVEF) was also performed. Results: The study included 150 patients (age 57±13 years, male gender 61%, admission weight 87±32 kg, LVEF 37±15%, 28% preserved LVEF).Mean initial andmaximum furosemide doses were 5.1±1.1 mg/h and 6.2±2.2 mg/h, respectively.Mean duration of therapy was 51.4±67.5 hours. Continuous infusion of furosemide was associated with a significant increase in mean hourly urine output compared to baseline (150±77 mL/h vs 116±69mL/h, P < .001). Acute renal injury developed in 19% of patients, with 70% of those occurring within the first 48 hours of therapy. Mean serum creatinine (baseline 1.55± 1.50 mg/dL vs at discharge 1.64± 1.61 mg/dL, P = .20) and estimated glomerular filtration rate (baseline 67±39 mL/min vs at discharge 67±43 mL/min, P = .89) did not significantly change over the course of the hospitalization. Development of acute renal injury was associated with poorer outcomes, higher furosemide dose, and longer duration of furosemide therapy. Diuretic response and safety were not different between patients with preserved or reduced LVEF. Conclusions: In patients with acute HF, furosemide administered as a low-dose continuous infusion was effective in achieving diuresis and was not associated with a detectable effect on renal function. This diuretic approach appeared to be similarly effective and safe in patients with preserved LVEF.